pharma Β· Ulcerative colitis Β· central nervous system (CNS) lymphomas Β· RANI
Rani Therapeutics Holdings
Rani Therapeutics Holdings trial registry β 7 ClinicalTrials.gov studies with program phase, status, and indication context.
San Jose, USA HQ
2012 Founded
99 Employees
Public company Type
RANI Β· NYSE Ticker
Company details
- Status
- Public
- HQ
- San Jose, USA
- Founded
- 2012
- Employees
- 99
- Programs
- 7
- Drugs
- 12
- Patents
- 148
Rani Therapeutics Holdings clinical trials
Registry index of 7 ClinicalTrials.gov studies linked to Rani Therapeutics Holdings programs β each row shows trial ID, program name, phase, status, and indication.
Rani Therapeutics Holdings trial registry β 7 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Rani Therapeutics Holdings.
-
GRT-1C101 β Phase 1
Clinical update -
GRT-1C102 β Phase 1
Clinical update -
Berubicin hydrochloride β Phase 2
Clinical update -
RT-114 is the RaniPill capsule with PG-102 for the treatment of obesity β Phase 1
Clinical update -
RaniPill capsule containing octreotide β Phase 1
Clinical update -
RT-102 (80 ΞΌg) β Phase 1
Clinical update -
Stelara β Phase 1
Clinical update
Trial registry
-
CTIS β -
CTIS β -
CTIS β -
CT.gov β -
CT.gov β -
CT.gov β -
CT.gov β